Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Psyched: DMT & SSRIs For Depression, MDMA Training, Negative Responses To Psychedelics & More
Psyched：抑鬱症的 DMT 和 SSRI、****訓練、對迷幻藥的負面反應等
Depression Relief: Possible Therapy Boost With DMT & SSRIs Small Pharma Clinical Results
緩解抑鬱症：DMT和SSRIs小型製藥臨床結果可能促進治療效果
New findings on safety, tolerability and efficacy from a clinical study assessing the interaction of psychedelics and traditional pharma for the treatment of major depressive disorder (MDD) are out.
一項評估迷幻藥與傳統藥物在治療重度抑鬱症（MDD）方面的相互作用的臨床研究得出了有關安全性、耐受性和有效性的新發現。
They correspond to U.K.'s short-acting psychedelic therapies developer Small Pharma's (OTC:DMTTF) open-label Phase 1b study assessing the joint work of its "native" DMT compound, SPL026 and selective serotonin reuptake inhibitors (SSRIs.) Read more HERE.
它們對應於英國。”的短效迷幻療法開發商 Small Pharma（場外交易代碼：DMTTF）的 1b 期開放標籤研究評估了其 “原生” DMT 化合物 SPL026 和選擇性血清素再攝取抑制劑（SSRI）的聯合作用。點擊此處閱讀更多。
Canadian Practitioners Can Now Enroll In MDMA-Assisted Psychotherapy Training Program, Legal Medical Psilocybin Access For Veteran Approved
加拿大從業人員現在可以報名參加****輔助心理治療培訓計劃，退伍軍人獲得合法醫療迷幻藥准入已獲批准
Canadian not...
加拿...
登入免費觀看全文
登入/註冊
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。